Title:
HETEROCYCLIC COMPOUND AS CSF-1R INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/134662
Kind Code:
A1
Abstract:
The present invention relates to a type of isoindolinone derivatives and use thereof in the preparation of a medicament for treating diseases associated with a novel colony stimulating factor 1 receptor (CSF-1R) inhibitor. In particular, the present invention relates to a compound of formula (I) and a pharmaceutically acceptable salt thereof or a stereoisomer thereof.
Inventors:
QIAN WENYUAN (CN)
YANG CHUNDAO (CN)
XU GUANGHAI (CN)
LI JIE (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
YANG CHUNDAO (CN)
XU GUANGHAI (CN)
LI JIE (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2019/070228
Publication Date:
July 11, 2019
Filing Date:
January 03, 2019
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D403/04; A61K31/4035; A61P35/00; A61P37/02; C07D209/12; C07D401/12; C07D403/12
Domestic Patent References:
| WO2012047017A2 | 2012-04-12 | |||
| WO2004108672A1 | 2004-12-16 |
Foreign References:
| US20100076051A1 | 2010-03-25 | |||
| US20110275630A1 | 2011-11-10 | |||
| US20050026976A1 | 2005-02-03 |
Other References:
See also references of EP 3738961A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: